Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Dec 27 2021

Neuroleptic Malignant Syndrome

  • Snapshot
    • A 32-year-old woman is brought to the psychiatric emergency department by emergency medical service for a suicidal attempt. The patient expressed to the hospital staff that she wishes to end her life due to concerns someone is attempting to kidnap her. She has a medical history of schizophrenia and has not been adherent to her aripiprazole. The patient attempted to attack 1 of the security guards due to the belief that he is involved in her kidnapping. She was given multiple doses of intramuscular haloperidol. Approximately 2 days later, the patient's temperature is 102°F (38.9°C), blood pressure is 163/95 mmHg, pulse is 115/min, and respirations are 26/min. On physical examination, the patient is diffusely rigid and is profusely diaphoretic.
  • Introduction
    • Overview
      • life-threatening neurologic and psychiatric emergency associated with neuroleptic (antipsychotic) medication use
      • classic clinical syndrome tetrad
        • altered mental status
        • fever
        • rigidity
        • autonomic instability
  • Epidemiology
    • Demographics
      • typically seen in young adults
        • can occur at any age
    • Risk factors
      • antipsychotic use
        • first- and second-generation
      • antiemetic use
        • e.g., metoclopramide and prochlorperazine
      • antiparkinson medication withdrawal
        • also called neuroleptic malignant-like syndrome or parkinsonism hyperpyrexia syndrome
  • ETIOLOGY
    • Pathophysiology
      • unknown but dopamine receptor blockade in the central nervous system is believed to be involved
    • Associated conditions
      • psychiatric disorders that require high or frequent doses of antipsychotic medications
  • Presentation
    • History
      • tetrad usually occurs over the course of 1-3 days after neuroleptic use
    • Physical exam
      • altered mental status
        • agitated delirium
        • confusion
        • catatonia
        • mutism
      • fever
        • ≥ 38°C
      • rigidity
        • typically diffuse
        • can be described as a "lead-pipe rigidity"
        • patients may also have a tremor (45-92% of cases)
      • autonomic instability
        • tachycardia
          • patients may develop dysrhythmias
        • hypertension or labile blood pressure
        • tachypnea
        • diaphoresis
      • hyporeflexia
  • Studies
    • Labs
      • ↑ creatine kinase
        • usually > 1000 U/L
      • basic metabolic panel
        • hypo- or hypernatremia
        • hyperkalemia
        • hypomagnesemia
        • hypocalcemia
        • metabolic acidosis
        • acute renal failure
          • may occure if myoglobinuria
      • ↓ iron concentration
        • sensitive but not specific
  • Differential
    • Serotonin syndrome
      • key distinguishing factors
        • acute onset
        • myoclonus
        • hyperreflexia
        • mydriasis (large pupils)
    • Malignant hyperthermia
      • key distinguishing factorss
        • offending agents are
          • halogenated inhalational anesthetics
          • succinylcholine
  • Treatment
    • Prevention
      • Conservative use of antipsychotics
      • Gradual titration of antopsychotics
    • Lifestyle
      • supportive care
        • indication
          • first-line in preventing further complications
            • intravenous fluids to prevent dehydration and acute kidney injury from myglobinuria
            • electrolyte repletion to prevent cardiac arrythmias and seizures
    • Pharmacologic
      • discontinue the offending agent
        • indication
          • first-line to prevent further progression of neuroleptic malignant syndrome
      • benzodiazepines
        • indication
          • usually initially used along with dantrolene in moderate or severe cases
        • medication
          • lorazepam
          • diazepam
      • dantrolene 
        • indication
          • usually given with benzodiazepines in moderate or severe cases
            • effective in relaxing skeletal muscles
      • bromocriptine
        • indication
          • administered after benzodiazepines and dantrolene is administered in order to restore dopaminergic tone
        • alternative agent
          • amantadine
  • Complications
    • Seizure
    • Cardiac dysrhythmia
    • Myocardial infarction
    • Respiratory failure
    • Hepatic failure
    • Acute renal failure
    • Deep venous thrombosis
    • Disseminated intravascular coagulation
  • Prognosis
    • Natural history of disease
      • most cases resolve within 2 weeks
    • Survival with treatment
      • improved
Card
1 of 0
Question
1 of 1
Private Note